Siren LLC’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$11.5M	Hold	821,513	–	–	0.59%	38
2025 Q1	$11.2M	Sell	821,513 -12,515	-2%	-$170K	0.63%	36
2024 Q4	$17M	Hold	834,028	–	–	0.75%	35
2024 Q3	$24.3M	Buy	+834,028	New	+$24.3M	1.21%	29